Professional
Added to YB: 2024-04-26
Pitch date: 2024-03-31
TEVA [bullish]
Teva Pharmaceutical Industries Limited
+112.27%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
Market Cap
$34.2B
Pitch Price
$14.18
Price Target
N/A
Dividend
N/A
EV/EBITDA
10.35
P/E
48.27
EV/Sales
2.92
Sector
Pharmaceuticals
Category
growth
Show full summary:
The Sound Shore Fund Portfolio Holding: Teva Pharmaceutical Industries Limited
TEVA: Doubled on 2024 guide beat, still trades at 10%+ FCF yield. Mgmt positioned co for growth w/ most promising branded drug pipeline in years. Manufactures generics + neuro & respiratory specialty drugs.
Read full article (1 min)